Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect-Reference-Cited by-同舟云学术

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect

Published:2018-03-20 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Petrosino Stefania,Cordaro Marika,Verde Roberta,Schiano Moriello Aniello,Marcolongo Gabriele,Schievano Carlo,Siracusa Rosalba,Piscitelli Fabiana,Peritore Alessio F.,Crupi Rosalia,Impellizzeri Daniela,Esposito Emanuela,Cuzzocrea Salvatore,Di Marzo Vincenzo

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference106 articles.

1. Increased levels of palmitoylethanolamide and other lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis;Abramo;BMC Vet. Res,2014

2. Ultramicronized palmitoylethanolamide counteracts the effects of compound 48/80 in a canine skin organ culture model;Abramo;Vet. Dermatol,2017

3. Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice;Ahmad;Brain Behav. Immun,2012

4. A proposed autacoid mechanism controlling mastocyte behaviour;Aloe;Agents Actions,1993

5. Identification of a widespread palmitoylethanolamide contamination in standard laboratory glassware;Angelini;Cannabis Cannabinoid Res,2017

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palmitoylethanolamide as a Supplement: The Importance of Dose-Dependent Effects for Improving Nervous Tissue Health in an In Vitro Model;International Journal of Molecular Sciences;2024-08-21

2. Ultramicronized N-palmitoylethanolamine associated with analgesics: Effects against persistent pain;Pharmacology & Therapeutics;2024-06

3. The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults;Clinical and Translational Neuroscience;2024-05-29

4. Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis;Nutrients;2024-05-28

5. Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders;Antioxidants;2024-05-14